Provides US Food and Drug Administration perspectives on the approval of transcatheter aortic valve replacement devices for patients at low surgical risk.
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue
Wu et al. (Wed,) studied this question.